The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 25, 2018

Filed:

Apr. 25, 2012
Applicants:

Vaniambadi Kalyanaraman, Rockville, MD (US);

Stephen Whitney, Silver Spring, MD (US);

Thomas C. Vancott, Brookeville, MD (US);

Victoria Polonis, Silver Spring, MD (US);

Carl Alving, Bethesda, MD (US);

Gary R. Matyas, Olney, MD (US);

Mangala Rao, Silver Spring, MD (US);

Mary Marovich, Bethesda, MD (US);

Francine Mccutchan, Silver Spring, MD (US);

Sodsai Tovanabutra, Gaithersburg, MD (US);

Eric Sanders-buell, Vienna, VA (US);

Inventors:

Vaniambadi Kalyanaraman, Rockville, MD (US);

Stephen Whitney, Silver Spring, MD (US);

Thomas C. VanCott, Brookeville, MD (US);

Victoria Polonis, Silver Spring, MD (US);

Carl Alving, Bethesda, MD (US);

Gary R. Matyas, Olney, MD (US);

Mangala Rao, Silver Spring, MD (US);

Mary Marovich, Bethesda, MD (US);

Francine McCutchan, Silver Spring, MD (US);

Sodsai Tovanabutra, Gaithersburg, MD (US);

Eric Sanders-Buell, Vienna, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); C07K 14/16 (2006.01); A61K 39/12 (2006.01); A61K 39/21 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); A61K 39/21 (2013.01); A61K 2039/53 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01);
Abstract

The instant application provides methods and related compositions pertaining to novel HIV envelope proteins. In some embodiments, the invention relates to methods and compositions for the preparation, production, and administration of isolated novel HIV envelope nucleic acid and protein sequences suitable, for example, as vaccines against HIV.


Find Patent Forward Citations

Loading…